REX Peptide ETF PEPT
Morningstar’s Analysis PEPT
There is no Morningstar’s Analysis data available.
- Current Portfolio Date
- Equity Holdings—
- Bond Holdings—
- Other Holdings—
- % Assets in Top 10 Holdings71.7
Top 10 Holdings | % Portfolio Weight | Market Value USD | Sector |
|---|---|---|---|
Eli Lilly and Co | 13.54 | 454,702 | Healthcare |
Ascendis Pharma AS | 11.20 | 376,183 | Healthcare |
Novo Nordisk AS ADR | 10.06 | 337,869 | Healthcare |
Insulet Corp | 7.98 | 268,060 | Healthcare |
Protagonist Therapeutics Inc | 6.08 | 204,282 | Healthcare |
Sanofi SA | 5.79 | 194,643 | Healthcare |
Rhythm Pharmaceuticals Inc | 5.77 | 193,924 | Healthcare |
Darling Ingredients Inc | 4.08 | 137,120 | Consumer Defensive |
Viking Therapeutics Inc | 3.89 | 130,701 | Healthcare |
Bachem Holding AG | 3.47 | 116,551 | Healthcare |